Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- manufacturers
- Thalidomide-O-C7-acid
-
-
2025-06-07
- CAS:2169266-70-8
- Min. Order: 100mg
- Purity: >95.00%
- Supply Ability: 100mg
|
| | Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- Basic information |
| Product Name: | Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- | | Synonyms: | Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-;Thalidomide 4'-ether-alkylC7-acid;Thalidomide-O-C7-acid;QUN 66708;8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)octanoic acid;Thalidomide-4-O-C7-COOH;8-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}octanoic acid;8-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]octanoic acid | | CAS: | 2169266-70-8 | | MF: | C21H24N2O7 | | MW: | 416.42 | | EINECS: | | | Product Categories: | | | Mol File: | 2169266-70-8.mol | ![Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- Structure](CAS/20210305/GIF/2169266-70-8.gif) |
| | Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- Chemical Properties |
| Boiling point | 699.1±55.0 °C(Predicted) | | density | 1.361±0.06 g/cm3(Predicted) | | pka | 4.77±0.10(Predicted) | | form | Solid | | color | White to off-white |
| | Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- Usage And Synthesis |
| Description | QUN 66708, also known as Thalidomide 4'-ether-alkylC7-acid is a cereblon ligand with alkyl linker and terminal acid for onward chemistry. This product has no formal name at the moment. | | Uses | Thalidomide-O-C7-acid is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. | | IC 50 | Cereblon | | storage | Store at -20°C | | References | [1] Sato T, et al. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine.Front Cell Dev Biol. 2021;9:629326. Published 2021 Mar 11. DOI:10.3389/fcell.2021.629326 [2] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-1008. DOI:10.1016/j.cell.2020.07.024 |
| | Octanoic acid, 8-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- Preparation Products And Raw materials |
|